PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Clinical trials for PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MS treatment study aims to control disease activity in china
Disease control Recruiting nowThis study is testing how well the drug ocrelizumab works to control multiple sclerosis (MS) in Chinese patients. It will include 60 people with either relapsing or primary progressive forms of MS. The main goals are to see if the drug reduces disease activity and to measure its …
Matched conditions: PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New MS therapy enters human testing
Disease control Recruiting nowThis early-stage study is testing a new therapy called TRX319 in adults with progressive forms of multiple sclerosis (MS). The main goals are to check if the treatment is safe, find the best dose, and see if a pre-treatment step is helpful. About 39 participants will be monitored…
Matched conditions: PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Cancer drug repurposed in bold bid to tame MS
Disease control Recruiting nowThis early-stage study is checking if a drug called ixazomib, used for a type of blood cancer, is safe for people with multiple sclerosis (MS). The goal is to see if it can reduce harmful antibodies linked to MS in the fluid around the brain and spine. About 72 participants with …
Matched conditions: PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE1 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Feb 24, 2026 14:06 UTC
-
Scientists use AI to unlock the Sleep-Fatigue puzzle in MS
Knowledge-focused Recruiting nowThis study aims to understand how sleep problems contribute to severe fatigue and thinking difficulties in people with multiple sclerosis (MS). Researchers will use detailed overnight sleep studies and thinking tests on about 382 people with MS and a comparison group. The goal is…
Matched conditions: PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC